Key result
Extracorporeal shock wave lithotripsy does not significantly increase hypertension risk compared with observation.
RCT (n=228)
Randomized
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To determine, in a randomized controlled clinical trial, the effect of extracorporeal shock wave lithotripsy (ESWL) on blood pressure. PATIENTS AND METHODS: The trial included 228 patients with small (< 15 mm) asymptomatic calyceal stones who were randomised to undergo ESWL (113 patients) or to an untreated (observed) control group (115 patients). Blood pressure was recorded at randomization using a standardized protocol. Patients undergoing ESWL received a mean (SD) of 5281 (3462) shocks over a mean of 1.75 sessions on one of two lithotripters. Patients were then followed annually, assessing blood pressure and changes in medication. Data were analysed on an intention-to-treat basis. RESULTS: At randomization, 43% of patients in the control group and 53% in the ESWL group were hypertensive. Of the 228 randomized, 200 patients completed at least one annual follow-up, of whom 192 (93 in the control and 99 in the ESWL group) had their blood pressure recorded. The mean follow-up was 2.2 years; 35 (37%) patients in the control and 46 (46%) in the ESWL group were hypertensive (P = 0.19). Seven (7%) patients in the control group and 11 (11%) in the ESWL group were newly diagnosed to be hypertensive (P = 0.35). CONCLUSIONS: In this randomized controlled clinical trial there was no evidence that ESWL causes changes in blood pressure.
No takes yet. Share an insight, caveat, or question.
Elves et al. (2000) conducted an RCT in Small (< 15 mm) asymptomatic calyceal stones (n=228). Extracorporeal shock wave lithotripsy (ESWL) vs. Untreated (observed) control group was evaluated on Hypertension at follow-up (p=0.19). Extracorporeal shock wave lithotripsy did not increase hypertension compared with observation.
Synapse has enriched 10 related papers. Consider them for comparative context: